DK1213972T3 - Komposition omfattende en alfa-amylase-inhibitor og mindst en fysiologisk acceptabel forbindelse, der kan nedsætte absorptionen af "hurtigere sukkere" i tarmen - Google Patents

Komposition omfattende en alfa-amylase-inhibitor og mindst en fysiologisk acceptabel forbindelse, der kan nedsætte absorptionen af "hurtigere sukkere" i tarmen

Info

Publication number
DK1213972T3
DK1213972T3 DK00958855T DK00958855T DK1213972T3 DK 1213972 T3 DK1213972 T3 DK 1213972T3 DK 00958855 T DK00958855 T DK 00958855T DK 00958855 T DK00958855 T DK 00958855T DK 1213972 T3 DK1213972 T3 DK 1213972T3
Authority
DK
Denmark
Prior art keywords
sugars
alpha
physiologically acceptable
acceptable compound
amylase inhibitor
Prior art date
Application number
DK00958855T
Other languages
Danish (da)
English (en)
Inventor
Nils Christian Mortensen
Original Assignee
Med Eq As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Med Eq As filed Critical Med Eq As
Application granted granted Critical
Publication of DK1213972T3 publication Critical patent/DK1213972T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Enzymes And Modification Thereof (AREA)
DK00958855T 1999-09-08 2000-09-08 Komposition omfattende en alfa-amylase-inhibitor og mindst en fysiologisk acceptabel forbindelse, der kan nedsætte absorptionen af "hurtigere sukkere" i tarmen DK1213972T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9921229.2A GB9921229D0 (en) 1999-09-08 1999-09-08 Compositions
PCT/GB2000/003472 WO2001017369A1 (en) 1999-09-08 2000-09-08 Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of 'fast sugars'

Publications (1)

Publication Number Publication Date
DK1213972T3 true DK1213972T3 (da) 2003-08-18

Family

ID=10860574

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00958855T DK1213972T3 (da) 1999-09-08 2000-09-08 Komposition omfattende en alfa-amylase-inhibitor og mindst en fysiologisk acceptabel forbindelse, der kan nedsætte absorptionen af "hurtigere sukkere" i tarmen

Country Status (14)

Country Link
EP (1) EP1213972B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003508467A (cg-RX-API-DMAC7.html)
KR (1) KR100594520B1 (cg-RX-API-DMAC7.html)
AT (1) ATE238689T1 (cg-RX-API-DMAC7.html)
AU (1) AU777044B2 (cg-RX-API-DMAC7.html)
CA (1) CA2383720A1 (cg-RX-API-DMAC7.html)
DE (1) DE60002484T2 (cg-RX-API-DMAC7.html)
DK (1) DK1213972T3 (cg-RX-API-DMAC7.html)
ES (1) ES2199174T3 (cg-RX-API-DMAC7.html)
GB (2) GB9921229D0 (cg-RX-API-DMAC7.html)
NO (1) NO314922B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ518167A (cg-RX-API-DMAC7.html)
PT (1) PT1213972E (cg-RX-API-DMAC7.html)
WO (1) WO2001017369A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601528B1 (en) 2000-12-23 2009-10-13 Elan Pharmaceuticals, Inc. Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease
US7217556B1 (en) 2000-12-23 2007-05-15 Pfizer Inc Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease
US7384773B1 (en) 2001-05-10 2008-06-10 Pfizer Inc Crystal of HIV protease-cleaved human beta secretase and method for crystallization thereof
US6797287B2 (en) 2001-09-25 2004-09-28 Pharmachem Laboratories, Inc. Phaseolamin compositions and methods for using the same
US7108869B2 (en) 2002-11-07 2006-09-19 Access Business Group International Llc Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
ITMI20030391A1 (it) * 2003-03-04 2004-09-05 S I I T S R L Servizio Internaz Ionale Imballa Formulazioni anticarie a base di faseolamina.
ITMI20052450A1 (it) * 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
JP5285852B2 (ja) * 2006-12-28 2013-09-11 株式会社ファンケル Dfaiiiの製造方法及びdfaiii高含有植物エキス
US20100330137A1 (en) * 2008-03-10 2010-12-30 Mauro Mantovani High bioavailability formulation of mangosteen and manufacturing process thereof
CN102292093B (zh) * 2009-02-02 2015-01-28 莱拉营养食品有限公司 用于代谢综合症控制的选自绒毛戴星草和莽吉柿的混合物
JP2011079752A (ja) * 2009-10-05 2011-04-21 Kracie Home Products Ltd 膵リパーゼ阻害剤並びにそれを含有する飲食品組成物及び医薬品組成物
CN103478738B (zh) * 2013-09-17 2016-02-10 深圳太太药业有限公司 一种具有减肥塑身及体重管理作用的组合物
EP3193899A1 (en) * 2014-09-19 2017-07-26 Nestec S.A. Methods and formulations for reducing absorption of carbohydrates in a companion animal
CN106036342A (zh) * 2016-06-14 2016-10-26 安徽平唐微食疗科技有限公司 适合于糖尿病人群食用的膳食补充固体饮料及其制备方法
IT201700078389A1 (it) * 2017-07-13 2019-01-13 Mv Medical Solutions Composizione utile nella prevenzione o trattamento degli stati di malassorbimento secondari a chirurgia bariatrica in soggetti obesi.
EP3975755A1 (en) * 2019-05-24 2022-04-06 Cosucra Groupe Warcoing S.A. Composition comprising inulin and protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
JP2757405B2 (ja) * 1988-12-09 1998-05-25 日清製粉株式会社 小麦から得られるα−アミラーゼインヒビターを含有するダイエット剤
US5612039A (en) * 1994-03-14 1997-03-18 Nini E. Policappelli Dietary supplement
JP2002535288A (ja) * 1999-01-22 2002-10-22 ウンツァ ディ マリア カルメラ マラッツィータ エッセ.ア.エッセ. リポタンパク質複合体およびそれらを含む組成物

Also Published As

Publication number Publication date
NO314922B1 (no) 2003-06-16
AU7026900A (en) 2001-04-10
KR100594520B1 (ko) 2006-07-19
GB2364498A (en) 2002-01-30
PT1213972E (pt) 2003-09-30
AU777044B2 (en) 2004-09-30
ATE238689T1 (de) 2003-05-15
DE60002484D1 (de) 2003-06-05
NZ518167A (en) 2003-03-28
CA2383720A1 (en) 2001-03-15
ES2199174T3 (es) 2004-02-16
NO20021160L (no) 2002-03-27
EP1213972A1 (en) 2002-06-19
JP2003508467A (ja) 2003-03-04
KR20020045605A (ko) 2002-06-19
GB9921229D0 (en) 1999-11-10
EP1213972B1 (en) 2003-05-02
NO20021160D0 (no) 2002-03-08
WO2001017369A1 (en) 2001-03-15
GB0127158D0 (en) 2002-01-02
DE60002484T2 (de) 2004-03-18

Similar Documents

Publication Publication Date Title
NO20021160D0 (no) Bestanddeler
BG104680A (en) Celecoxib compositions
AU2002256093A1 (en) Bulking agents as satiety agents
PT1075258E (pt) Analogos gordos novos para o tratamento da obesidade
TR200100805T2 (tr) Tetrahidropiridoeterler
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
TR200100448T2 (tr) Fenil ksantin türevleri
WO2007130075A8 (en) Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
IS7545A (is) 7-Arýl-3,9-díasabísýkló(3.3.1)nón-6-en afleiður og notkun þeirra sem renín hindra í meðferð á háþrýstingi, hjarta- og æða- eða nýrna sjúkdómum
CA2356320A1 (en) Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
IL156827A (en) Derivatives of 2-mercapto- [3,1] thiazolo [4,5 [b- pyridine and pharmaceutical preparations containing them for the treatment of cardiovascular disease
DK1161228T3 (da) Præparat omfattende isoquercetin og ascorbinsyre i en sustained release-form
ATE485049T1 (de) Physiologisch aktive zusammensetzung gegen diabetes
AP2001002377A0 (en) Substituted phenoxyacetic acids.
JP2003508467A5 (cg-RX-API-DMAC7.html)
CA2501321A1 (en) Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
EA200701068A1 (ru) Применение антиоксидантных соединений для восстановления мышц
AU2003280314A1 (en) Composition for the treatment of gastrointestinal disorders
EP1068868A3 (en) Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
WO2004037166A3 (en) Therapeutic guanidines
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
SI1492521T1 (sl) Kombinirana uporaba l-karnitina, acetil l-karnitina in propil l-karnitina za zdravljenje oligoastenoteratospermije
IL150977A (en) Use of protein source for preparation of a nutitional composition for maintaining or improving the synthesis of mucins
IS6676A (is) Amínóalkenýlbensóýl-bensófúran eða bensóþíófenafleiður, aðferð til framleiðslu þeirra og samsetningar sem innihalda þær
YU58102A (sh) Postupak za održavanje ili poboljšanje sinteze mucina